CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Analysis of Bioanalytical Services Market

Analysis of Bioanalytical Services...

Trudiagnostic Unveils Truage PACE For Tracking Biological Aging Rate

Trudiagnostic Unveils Truage PACE For...

Know More About the Comprehensive Bioanalytical Testing Services

Know More About the Comprehensive...

Ways Bioanalytical Laboratory Automation Boosts Efficiency and Accuracy

Ways Bioanalytical Laboratory...

Analytics' Role in Pharmaceutical Success

Analytics' Role in Pharmaceutical...

Discovering and developing drugs using bioanalysis

Discovering and developing drugs...

Developing Next-Generation Technologies for a Better Tomorrow

Developing Next-Generation...

Why Outsource Bioanalysis Work?

Why Outsource Bioanalysis Work?

Analysis of Bioanalytical Services Market

Analysis of Bioanalytical Services...

Trudiagnostic Unveils Truage PACE For Tracking Biological Aging Rate

Trudiagnostic Unveils Truage PACE For...

Know More About the Comprehensive Bioanalytical Testing Services

Know More About the Comprehensive...

Ways Bioanalytical Laboratory Automation Boosts Efficiency and Accuracy

Ways Bioanalytical Laboratory...

Analytics' Role in Pharmaceutical Success

Analytics' Role in Pharmaceutical...

Discovering and developing drugs using bioanalysis

Discovering and developing drugs...

Developing Next-Generation Technologies for a Better Tomorrow

Developing Next-Generation...

Why Outsource Bioanalysis Work?

Why Outsource Bioanalysis Work?

Merakris Therapeutics Partners with Miracles In Sight Eye Bank

Life Sciences Review Life Sciences Review | Thursday, July 29, 2021
Tweet

Merakris Therapeutics has signed an agreement with Miracles In Sight (MIS) to provide Opticyte Amniotic Ophthalmic Repair Grafts to MIS-affiliated eye doctors in three states.


FREMONT, CA: Merakris Therapeutics, based in Research Triangle Park, has signed an agreement with Miracles In Sight (MIS) to provide Opticyte Amniotic Ophthalmic Repair Grafts to MIS-affiliated eye doctors in three states.


One of the largest non-profit eye banks globally, MIS offers highly advanced corneal tissue for transplantation to restore, preserve, and improve vision. The North Carolina-based company Winston-Salem collaborates with worldwide innovators to test novel techniques and solutions that address emerging ophthalmic concerns. Through the Merakris collaboration, MIS is connected with more than 70 eye clinics in North and South Carolina and Texas, who will now have easy access to Opticyte.


The Opticyte Amniotic Ophthalmic Repair Grafts are a biological barrier that shields the eye's corneal surface while recovering and helps avoid scar tissue formation. 


The substance promotes cell adhesion and ingrowth, and it's frequently employed as an additional biological barrier in individuals with dry eye disease or other corneal abnormalities. The grafts, made from an amniotic membrane, come in several shapes and sizes to meet various surgical demands.


"We are excited to begin this new partnership with Miracles In Sight as we continue to grow through new additions to the Merakris family of products," said Chris Broderick, the company's CEO. "During the past year we have launched Opticyte through a variety of channels, ranging from business-to-business sales to strategic partnerships like this one. We know the MIS team well and we are eager to fully support their clinics across these three service areas."


"At Miracles in Sight, our mission is to support the restoration, preservation and enhancement of site,"  said Kristen McCoy, vice president of Surgical Applications. "This partnership aligns with our mission and allows us to expand our service options. We are excited to work with Merakris to make the Opticyte product available to our community of physicians."


Weekly Brief

loading
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/merakris-therapeutics-partners-with-miracles-in-sight-eye-bank-nwid-474.html